Coamorphous Atorvastatin Calcium to Improve its Physicochemical and Pharmacokinetic Properties
Open Access
- 3 September 2013
- journal article
- Published by Frontiers Media SA in Journal of Pharmacy & Pharmaceutical Sciences
- Vol. 16 (4) , 577-587
Abstract
Purpose: Atorvastatin calcium (ATC) is classified as class II (low solubility and high permeability) compound according to the biopharmaceutical classification system. The amorphous form of ATC possesses higher solubility, dissolution rate, and bioavailability than its crystalline form. Coamorphous drug system is a new and emerging method to prepare stable amorphous forms, in this case leading to the improved stability of ATC in dissolution medium. Methods: In this study, coamorphous form of ATC and nicotinamide (ATC-NIC) was prepared from solvent evaporation method and characterized using differential scanning calorimetry (DSC), Fourier transform infrared spectroscopy (FT-IR) and powder X-ray diffraction (PXRD). The intrinsic dissolution rate and solubility of ATC-NIC were determined along with plasma concentrations of ATC using HPLC after oral dosing in rats. Results: The crystalline ATC was converted to coamorphous form revealing a molecular interaction between ATC and NIC. The intrinsic dissolution rate, solubility and plasma concentration of coamorphous ATC-NIC are higher than those of crystalline ATC. ATC-NIC coamorphous system showed greater solution stability than those reported in the literature for amorphous ATC. Conclusions: Coamorphous ATC-NIC has improved physicochemical and pharmacokinetic properties as compared to ATC. This article is open to POST-PUBLICATION REVIEW. Registered readers (see “For Readers”) may comment by clicking on ABSTRACT on the issue’s contents page.Keywords
This publication has 35 references indexed in Scilit:
- Amino acids as co-amorphous stabilizers for poorly water soluble drugs – Part 1: Preparation, stability and dissolution enhancementEuropean Journal of Pharmaceutics and Biopharmaceutics, 2013
- Bridging solubility between drug discovery and developmentDrug Discovery Today, 2012
- Modification of physicochemical characteristics of active pharmaceutical ingredients and application of supersaturatable dosage forms for improving bioavailability of poorly absorbed drugsAdvanced Drug Delivery Reviews, 2012
- Co-amorphous simvastatin and glipizide combinations show improved physical stability without evidence of intermolecular interactionsEuropean Journal of Pharmaceutics and Biopharmaceutics, 2012
- Enhanced bioavailability of nano-sized chitosan–atorvastatin conjugate after oral administration to ratsEuropean Journal of Pharmaceutical Sciences, 2011
- Biopharmaceutical classification of drugs using intrinsic dissolution rate (IDR) and rat intestinal permeabilityEuropean Journal of Pharmaceutics and Biopharmaceutics, 2009
- Physical characterization and stability of amorphous indomethacin and ranitidine hydrochloride binary systems prepared by mechanical activationEuropean Journal of Pharmaceutics and Biopharmaceutics, 2009
- Preparation, characterization and in vivo evaluation of amorphous atorvastatin calcium nanoparticles using supercritical antisolvent (SAS) processEuropean Journal of Pharmaceutics and Biopharmaceutics, 2008
- Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution ratesAdvanced Drug Delivery Reviews, 2007
- Predicting Drug Disposition via Application of BCS: Transport/Absorption/ Elimination Interplay and Development of a Biopharmaceutics Drug Disposition Classification SystemPharmaceutical Research, 2005